CFP
BSX icon

Cascade Financial Partners’s Boston Scientific BSX Stock Holding History

Cascade Financial Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,869
Closed -$274K – 269
2025
Q4 		$274K Hold
2,869
– – 0.03% 220
2025
Q3 		$280K Hold
2,869
– – 0.03% 210
2025
Q2 		$308K Hold
2,869
– – 0.04% 200
2025
Q1 		$289K Sell
2,869
-58
-2% -$5.84K 0.04% 199
2024
Q4 		$261K Buy
2,927
+58
+2% +$5.11K 0.03% 206
2024
Q3 		$253K Hold
2,869
– – 0.03% 209
2024
Q2 		$221K Buy
+2,869
New +$210K 0.03% 217

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cascade Financial Partners's BSX Position: Q1 2026 in Review

Cascade Financial Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,869 shares — an estimated $274K sold.

Cascade Financial Partners first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $308K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Cascade Financial Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Cascade Financial Partners sold 2,869 Boston Scientific shares in Q1 2026, an estimated $274K.
  • Cascade Financial Partners first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
  • Cascade Financial Partners's Boston Scientific position peaked at $308K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cascade Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.